Anxiety, Depression
Conditions
Keywords
Meditation, Dialysis
Brief summary
This study examines the use of brief meditation interventions for patients with symptoms of anxiety and depression who are undergoing dialysis. Half of the participants will receive meditation interventions 3 times a week, while the other half will receive treatment as usual. This study will examine whether meditation is feasible and whether it has any effect on reducing symptoms of anxiety or depression.
Detailed description
Roughly 50% of people who undergo dialysis experience stress, anxiety or depression, but often these conditions go undetected and untreated. It is known that meditation is helpful for anxiety and depression, especially in people who have chronic health conditions. This study will look specifically at meditation interventions tailored to the dialysis setting. Patients on maintenance hemodialysis with anxiety and depression will be recruited from hemodialysis units. Recruitment will start at the Jewish General Hospital in March 2016. Recruitment may later expand to University Health Network (Toronto), and/or other sites affiliated with McGill University or University of Toronto. Participants will then be randomly assigned to receive meditation or continue with their usual treatment. The participants assigned to the meditation group will practice several meditation techniques with a trained interventionist 3 times a week, during their dialysis sessions. At the end of the 8 weeks, the investigators will assess whether the meditation intervention was feasible (i.e. whether recruitment goals were met and drop out rates were as expected). Participants in the meditation group will be asked to rate whether they enjoyed the meditation on a scale. Both the participants assigned to the meditation group and to the usual treatment group will be asked to rate their depression and anxiety symptoms on the PHQ-9 and the GAD-7 scales to evaluate whether there was any change.
Interventions
OTHERMeditation
10-15 minutes of individually conducted medication practices (silent meditations, guided meditations, body scans, gentle arm movement exercises).
Sponsors
University Health Network, Toronto
Sunnybrook Health Sciences Centre
Lady Davis Institute
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patients currently receiving maintenance hemodialysis * Patients with depression and/or anxiety as indicated by scores of ≥10 on the Patient Health Questionnaire (PHQ-9) and/or General Anxiety Disorder-7 (GAD- 7) * Normal cognition or Mild Cognitive Impairment (Normal Result on the 3-minute Mini-Cog Test)
Exclusion criteria
* Mild, Moderate, or Severe Dementia (Abnormal Result on the 3-minute Mini-Cog Test) * Acute psychotic symptoms * Acute Suicidal ideation/intent
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Proportion of participants screened as eligible who enroll | 34 months | — |
| Proportion of participants who enrolled who completed the 8 week-trial | 34 months | — |
| Tolerability of Meditation Intervention on a 10-point Likert scale | 8 weeks | Tolerability of intervention on a 10-point Likert scale |
Secondary
| Measure | Time frame |
|---|---|
| Change in Patient Health Questionnaire (PHQ-9) | Baseline and at 8 weeks |
| Change in General Anxiety Disorder-7 (GAD-7) | Baseline and at 8 weeks |
Countries
Canada
Outcome results
None listed